{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T12:59:20Z","timestamp":1780750760970,"version":"3.54.1"},"publisher-location":"New York, NY","reference-count":25,"publisher":"Springer US","isbn-type":[{"value":"9781071647295","type":"print"},{"value":"9781071647301","type":"electronic"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1007\/978-1-0716-4730-1_19","type":"book-chapter","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T12:59:13Z","timestamp":1753707553000},"page":"285-303","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Use of Glucose\/Fructose to Enhance the Exon Skipping Efficacy"],"prefix":"10.1007","author":[{"given":"Gang","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HaiFang","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,29]]},"reference":[{"key":"19_CR1","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/humu.20918","volume":"30","author":"A Aartsma-Rus","year":"2009","unstructured":"Aartsma-Rus A, Fokkema I, Verschuuren J et al (2009) Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations. Hum Mutat 30:293\u2013299","journal-title":"Hum Mutat"},{"key":"19_CR2","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/nm897","volume":"9","author":"QL Lu","year":"2003","unstructured":"Lu QL, Mann CJ, Lou F et al (2003) Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse. Nat Med 9:1009\u20131014","journal-title":"Nat Med"},{"key":"19_CR3","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1073\/pnas.0406700102","volume":"102","author":"QL Lu","year":"2005","unstructured":"Lu QL, Rabinowitz A, Chen YC et al (2005) Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles. Proc Natl Acad Sci USA 102:198\u2013203","journal-title":"Proc Natl Acad Sci USA"},{"key":"19_CR4","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/sj.mt.6300329","volume":"16","author":"H Yin","year":"2008","unstructured":"Yin H, Lu Q, Wood M (2008) Effective exon skipping and restoration of dystrophin expression by peptide nucleic acid antisense oligonucleotides in mdx mice. Mol Ther 16:38\u201345","journal-title":"Mol Ther"},{"key":"19_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0181065","volume":"12","author":"VB Pires","year":"2017","unstructured":"Pires VB, Simoes R, Mamchaoui K et al (2017) Short (16-mer) locked nucleic acid splice-switching oligonucleotides restore dystrophin production in Duchenne muscular dystrophy myotubes. PLoS One 12:e0181065","journal-title":"PLoS One"},{"key":"19_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0061584","volume":"8","author":"L Yang","year":"2013","unstructured":"Yang L, Niu H, Gao X et al (2013) Effective exon skipping and dystrophin restoration by 2\u2032-o-methoxyethyl antisense oligonucleotide in dystrophin-deficient mice. PLoS One 8:e61584","journal-title":"PLoS One"},{"key":"19_CR7","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/nrneurol.2016.180","volume":"12","author":"JJ Dowling","year":"2016","unstructured":"Dowling JJ (2016) Eteplirsen therapy for Duchenne muscular dystrophy: skipping to the front of the line. Nat Rev Neurol 12:675\u2013676","journal-title":"Nat Rev Neurol"},{"key":"19_CR8","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1056\/NEJMoa1011367","volume":"364","author":"NM Goemans","year":"2011","unstructured":"Goemans NM, Tulinius M, van den Akker JT et al (2011) Systemic administration of PRO051 in Duchenne\u2019s muscular dystrophy. N Engl J Med 364:1513\u20131522","journal-title":"N Engl J Med"},{"key":"19_CR9","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/S0140-6736(11)60756-3","volume":"378","author":"S Cirak","year":"2011","unstructured":"Cirak S, Arechavala-Gomeza V, Guglieri M et al (2011) Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study. Lancet 378:595\u2013605","journal-title":"Lancet"},{"key":"19_CR10","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1472-6750-8-35","volume":"8","author":"JH Williams","year":"2008","unstructured":"Williams JH, Schray RC, Sirsi SR et al (2008) Nanopolymers improve delivery of exon skipping oligonucleotides and concomitant dystrophin expression in skeletal muscle of mdx mice. BMC Biotechnol 8:35","journal-title":"BMC Biotechnol"},{"key":"19_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-3155-7-1","volume":"7","author":"SR Sirsi","year":"2009","unstructured":"Sirsi SR, Schray RC, Wheatley MA et al (2009) Formulation of polylactide-co-glycolic acid nanospheres for encapsulation and sustained release of poly(ethylene imine)-poly(ethylene glycol) copolymers complexed to oligonucleotides. J Nanobiotechnol 7:1","journal-title":"J Nanobiotechnol"},{"key":"19_CR12","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.jconrel.2008.10.020","volume":"134","author":"Y Kim","year":"2009","unstructured":"Kim Y, Tewari M, Pajerowski JD et al (2009) Polymersome delivery of siRNA and antisense oligonucleotides. J Control Release 134:132\u2013140","journal-title":"J Control Release"},{"key":"19_CR13","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/mt.2009.8","volume":"17","author":"P Rimessi","year":"2009","unstructured":"Rimessi P, Sabatelli P, Fabris M et al (2009) Cationic PMMA nanoparticles bind and deliver antisense oligoribonucleotides allowing restoration of dystrophin expression in the mdx mouse. Mol Ther 17:820\u2013827","journal-title":"Mol Ther"},{"key":"19_CR14","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/gt.2009.145","volume":"17","author":"A Ferlini","year":"2010","unstructured":"Ferlini A, Sabatelli P, Fabris M et al (2010) Dystrophin restoration in skeletal, heart and skin arrector pili smooth muscle of mdx mice by ZM2 NP-AON complexes. Gene Ther 17:432\u2013438","journal-title":"Gene Ther"},{"key":"19_CR15","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/897076","volume":"2012","author":"E Bassi","year":"2012","unstructured":"Bassi E, Falzarano S, Fabris M et al (2012) Persistent dystrophin protein restoration 90 days after a course of intraperitoneally administered naked 2\u2019OMePS AON and ZM2 NP-AON complexes in mdx mice. J Biomed Biotechnol 2012:897076","journal-title":"J Biomed Biotechnol"},{"key":"19_CR16","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/527418","volume":"2013","author":"MS Falzarano","year":"2013","unstructured":"Falzarano MS, Passarelli C, Bassi E et al (2013) Biodistribution and molecular studies on orally administered nanoparticle-AON complexes encapsulated with alginate aiming at inducing dystrophin rescue in mdx mice. Biomed Res Int 2013:527418","journal-title":"Biomed Res Int"},{"key":"19_CR17","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s00018-009-0186-0","volume":"67","author":"F Said Hassane","year":"2010","unstructured":"Said Hassane F, Saleh AF, Abes R et al (2010) Cell penetrating peptides: overview and applications to the delivery of oligonucleotides. Cell Mol Life Sci 67:715\u2013726","journal-title":"Cell Mol Life Sci"},{"key":"19_CR18","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.1093\/hmg\/ddn293","volume":"17","author":"H Yin","year":"2008","unstructured":"Yin H, Moulton HM, Seow Y et al (2008) Cell-penetrating peptide-conjugated antisense oligonucleotides restore systemic muscle and cardiac dystrophin expression and function. Hum Mol Genet 17:3909\u20133918","journal-title":"Hum Mol Genet"},{"key":"19_CR19","doi-asserted-by":"publisher","first-page":"4405","DOI":"10.1093\/hmg\/ddp395","volume":"18","author":"H Yin","year":"2009","unstructured":"Yin H, Moulton HM, Betts C et al (2009) A fusion peptide directs enhanced systemic dystrophin exon skipping and functional restoration in dystrophin-deficient mdx mice. Hum Mol Genet 18:4405\u20134414","journal-title":"Hum Mol Genet"},{"key":"19_CR20","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1038\/mt.2010.151","volume":"18","author":"H Yin","year":"2010","unstructured":"Yin H, Moulton HM, Betts C et al (2010) Functional rescue of dystrophin-deficient mdx mice by a chimeric peptide-PMO. Mol Ther 18:1822\u20131829","journal-title":"Mol Ther"},{"key":"19_CR21","doi-asserted-by":"publisher","first-page":"10962","DOI":"10.1073\/pnas.1605731113","volume":"113","author":"SM Hammond","year":"2016","unstructured":"Hammond SM, Hazell G, Shabanpoor F et al (2016) Systemic peptide-mediated oligonucleotide therapy improves long-term survival in spinal muscular atrophy. Proc Natl Acad Sci USA 113:10962\u201310967","journal-title":"Proc Natl Acad Sci USA"},{"key":"19_CR22","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1038\/mt.2011.79","volume":"19","author":"H Yin","year":"2011","unstructured":"Yin H, Saleh AF, Betts C et al (2011) Pip5 transduction peptides direct high efficiency oligonucleotide-mediated dystrophin exon skipping in heart and phenotypic correction in mdx mice. Mol Ther 19:1295\u20131303","journal-title":"Mol Ther"},{"key":"19_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2012.30","volume":"1","author":"C Betts","year":"2012","unstructured":"Betts C, Saleh AF, Arzumanov AA et al (2012) Pip6-PMO, a new generation of peptide-oligonucleotide conjugates with improved cardiac exon skipping activity for DMD treatment. Mol Ther Nucleic Acids 1:e38","journal-title":"Mol Ther Nucleic Acids"},{"key":"19_CR24","doi-asserted-by":"publisher","first-page":"10981","DOI":"10.1038\/ncomms10981","volume":"7","author":"G Han","year":"2016","unstructured":"Han G, Gu B, Cao L et al (2016) Hexose enhances oligonucleotide delivery and exon skipping in dystrophin-deficient mdx mice. Nat Commun 7:10981","journal-title":"Nat Commun"},{"key":"19_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2016.46","volume":"5","author":"L Cao","year":"2016","unstructured":"Cao L, Han G, Lin C et al (2016) Fructose promotes uptake and activity of oligonucleotides with different chemistries in a context-dependent manner in mdx mice. Mol Ther Nucleic Acids 5:e329","journal-title":"Mol Ther Nucleic Acids"}],"container-title":["Methods in Molecular Biology","Exon Skipping and Inclusion Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-4730-1_19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T12:06:14Z","timestamp":1780747574000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-4730-1_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9781071647295","9781071647301"],"references-count":25,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-4730-1_19","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"29 July 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}